通讯作者: 黄旸木, ymhuang@bjmu.edu.cn

DOI：10.12201/bmr.202410.00027

Construction of country prioritizing index system for China’s international vaccine cooperation

• 摘要：目的：构建中国国际疫苗合作优先国家筛选指标体系,为中国选择疫苗合作国家提供筛选工具和指标参考。方法：根据PESTEL分析模型,通过文献研究和专家访谈初步确定指标体系,借助专家咨询完善并确定指标体系,采用层次分析法确定指标权重。结果：构建了中国国际疫苗合作优先国家筛选指标体系。该指标体系涵盖了经济、政治、社会、科技、法律与规章5个因素,下设15个二级指标,细分了34个三级指标。法律与规章因素权重最高,为0.48,经济因素权重为0.23,政治因素权重为0.15,社会因素权重为0.095,科技因素权重为0.045。专家权威程度和意见协调程度均较好。层次分析法中所有判断矩阵均通过一致性检验,指标权重结果可信。结论：研究构建了中国开展国际疫苗合作优先国家筛选指标体系,构建过程科学可靠,可为中国疫苗合作国家的筛选提供参考。

  关键词： 疫苗合作; 指标体系; 市场选择; 全球公共产品

   

  Abstract: Objective: To construct a country prioritization index system for Chinas international vaccine cooperation, and provide a screening tool and indicator references for Chinas primary selection of vaccine cooperation countries. Method: Based on the PESTEL analysis model, the indicator system was preliminarily determined through literature research and expert interviews. With the help of expert consultation, the indicator system was improved and finalized. The weight of the indicators was determined using the Analytic Hierarchy Process. Result: A screening index system for priority countries in Chinas international vaccine cooperation has been established. This indicator system covers 5 factors including economy, politics, society, technology, law, and regulations, with 15 secondary indicators and 34 tertiary indicators subdivided. The legal and regulatory factors have the highest weight at 0.48, economic factors at 0.23, political factors at 0.15, social factors at 0.095, and technological factors at 0.045. The authority and coordination of opinions of experts are both good. All judgment matrices in the Analytic Hierarchy Process have passed the consistency test, and the weight results of the indicators are reliable. Conclusion: The study has established an index system for Chinas prioritization of international vaccine countries, and the construction process is scientific and reliable, which can provide reference for the selection of Chinas vaccine cooperation countries.

  Key words: Vaccine Cooperation；Index System; Market Selection; Global Public Goods; 

  提交时间：2024-10-11

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 黄玉梅, 关丽征, 孙力光, 陈瑞, 韩优莉, 王亚东, 张柠, 曾雁冰, 马骋宇, 李颖. 健康中国战略下慢性病防控多部门合作评价指标体系构建研究. 2024. doi: 10.12201/bmr.202407.00014

  李行, 蒋泓. “一带一路”发展中国家妇幼卫生培训评价指标体系构建. 2022. doi: 10.12201/bmr.202207.00030

  钟辰阳, 黄葭燕. 卫生发展援助动因分析指标体系构建. 2024. doi: 10.12201/bmr.202410.00028

  杨柳, 李小龙, 李善平, 吴义熔. 电子病历数据质量评估指标体系构建研究. 2023. doi: 10.12201/bmr.202303.00021

  路杰. “区块链+”疫苗可信追溯系统构建及应用. 2021. doi: 10.12201/bmr.202109.00005

  王欣媛, 徐佳苗, 刘健, 郁昕怡, 黄晓光. 基于层次分析法的区域医疗中心评价指标体系构建研究. 2023. doi: 10.12201/bmr.202303.00011

  田瑞. 移动社交媒体中疾病类健康信息评价指标体系构建及实证研究. 2024. doi: 10.12201/bmr.202410.00003

  石欣怡, 彭明瑶, 张子楠, 王中华. 紧密型医共体整合健康管理服务能力综合评价指标体系构建研究. 2023. doi: 10.12201/bmr.202312.00005

  兰小梦, 潘杰, 赵莉. 健康示范县评价指标体系构建——基于德尔菲和层次分析法. 2024. doi: 10.12201/bmr.202407.00016

  王先菊, 司建平, 郭清. 居家社区中医药特色医养结合服务绩效评价指标体系构建研究. 2023. doi: 10.12201/bmr.202312.00004

• 序号	提交日期	编号	操作
  1	2024-06-07	bmr.202410.00027V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论